Gradient Investments’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-17
| Closed | -$166 | – | 1174 |
|
|
2024
Q2 | $166 | Buy |
+17
| New | +$207 | ﹤0.01% | 1282 |
|
|
2024
Q1 | – | Sell |
-233
| Closed | -$5.02K | – | 1777 |
|
|
2023
Q4 | $5.02K | Hold |
233
| – | – | ﹤0.01% | 994 |
|
|
2023
Q3 | $4.33K | Hold |
233
| – | – | ﹤0.01% | 986 |
|
|
2023
Q2 | $5.9K | Hold |
233
| – | – | ﹤0.01% | 921 |
|
|
2023
Q1 | $6.04K | Hold |
233
| – | – | ﹤0.01% | 909 |
|
|
2022
Q4 | $5.51K | Hold |
233
| – | – | ﹤0.01% | 915 |
|
|
2022
Q3 | $6K | Sell |
233
-35
| -13% | -$1.23K | ﹤0.01% | 931 |
|
|
2022
Q2 | $9K | Buy |
268
+35
| +15% | +$1.49K | ﹤0.01% | 801 |
|
|
2022
Q1 | $17K | Sell |
233
-2
| -0.9% | -$144 | ﹤0.01% | 682 |
|
|
2021
Q4 | $22K | Sell |
235
-2
| -0.8% | -$239 | ﹤0.01% | 640 |
|
|
2021
Q3 | $30K | Sell |
237
-46
| -16% | -$6.7K | ﹤0.01% | 575 |
|
|
2021
Q2 | $47K | Sell |
283
-16,502
| -98% | -$2.67M | ﹤0.01% | 478 |
|
|
2021
Q1 | $3.05M | Buy |
16,785
+12,491
| +291% | +$2.9M | 0.1% | 153 |
|
|
2020
Q4 | $941K | Sell |
4,294
-135
| -3% | -$27.4K | 0.04% | 160 |
|
|
2020
Q3 | $971K | Sell |
4,429
-5,145
| -54% | -$1.09M | 0.04% | 158 |
|
|
2020
Q2 | $1.83M | Sell |
9,574
-3,871
| -29% | -$678K | 0.08% | 146 |
|
|
2020
Q1 | $2.08M | Sell |
13,445
-3,086
| -19% | -$359K | 0.11% | 129 |
|
|
2019
Q4 | $1.38M | Sell |
16,531
-458
| -3% | -$34.9K | 0.06% | 178 |
|
|
2019
Q3 | $1.15M | Buy |
16,989
+2,365
| +16% | +$156K | 0.06% | 183 |
|
|
2019
Q2 | $971K | Buy |
14,624
+7,400
| +102% | +$431K | 0.05% | 191 |
|
|
2019
Q1 | $402K | Buy |
+7,224
| New | +$441K | 0.03% | 197 |
|
|
2018
Q4 | – | Sell |
-566
| Closed | -$49K | – | 1082 |
|
|
2018
Q3 | $49K | Hold |
566
| – | – | ﹤0.01% | 364 |
|
|
2018
Q2 | $33K | Hold |
566
| – | – | ﹤0.01% | 396 |
|
|
2018
Q1 | $23K | Hold |
566
| – | – | ﹤0.01% | 454 |
|
|
2017
Q4 | $20K | Buy |
+566
| New | +$18.8K | ﹤0.01% | 475 |
|
|
2017
Q3 | – | Sell |
-566
| Closed | -$20K | – | 658 |
|
|
2017
Q2 | $20K | Hold |
566
| – | – | ﹤0.01% | 391 |
|
|
2017
Q1 | $14K | Hold |
566
| – | – | ﹤0.01% | 460 |
|
|
2016
Q4 | $9K | Hold |
566
| – | – | ﹤0.01% | 470 |
|
|
2016
Q3 | $10K | Hold |
566
| – | – | ﹤0.01% | 455 |
|
|
2016
Q2 | $9K | Sell |
566
-26,986
| -98% | -$315K | ﹤0.01% | 449 |
|
|
2016
Q1 | $264K | Buy |
+27,552
| New | +$391K | 0.03% | 159 |
|
Other funds holding TDOC
RCMNY
Gradient Investments's TDOC Position: Q3 2024 in Review
Gradient Investments sold out of Teladoc Health (TDOC) in Q3 2024, closing a stake of 17 shares — an estimated $166 sold.
Gradient Investments first reported a position in TDOC in Q1 2016 and held it in 31 quarters. The position peaked at $3.05M in Q1 2021. 366 funds tracked by Wall St. Rank hold TDOC as of Q3 2024.
- Gradient Investments reported no remaining Teladoc Health position as of Q3 2024 after selling out during the quarter.
- Gradient Investments sold 17 Teladoc Health shares in Q3 2024, an estimated $166.
- Gradient Investments first reported a position in Teladoc Health in Q1 2016 and held it in 31 quarters.
- Gradient Investments's Teladoc Health position peaked at $3.05M in Q1 2021.
- 366 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2024.
Based on Gradient Investments's 13F filing for Q3 2024, filed 15 Oct 2024.